Skip to main content
OpenTrials
Completed

NCT Number: NCT06313021

Turkish Version of the Brief Assessment of Cognitive Impairment in Individuals With Stroke Scale

Cognitive processing involves many interrelated cognitive domains, such as performing daily tasks, attention, language, and memory. 70% of individuals with stroke experience cognitive problems. Due to cognitive problems, individuals with stroke have difficulty processing and planning information. This situation negatively affects daily living activities and returning to work. Cognitive disorders that occur after stroke negatively affect the functional independence of individuals. At the same time, individuals with stroke have difficulty structuring and organizing information. The individual may not be able to pay sufficient attention during the activity in terms of planning, automatic attention and adaptation to the stages required by the job.

Cognitive evaluation should include cognition, orientation, and higher cortical functions because the cognitive process is a very complex process. Assessment methods frequently used in cognitive evaluation of stroke patients; Scales and tests such as Simple Mental Test, Mini Mental State Test, Montreal Cognitive Assessment Scale, Wechsler Memory and Intelligence Test are used. General problems with these evaluations; Some of them have a long application period, some of them have problems in perception of the patients, and some of them have a low power to distinguish the cognitive problems of the patients. When the Brief Assessment of Cognitive Impairment Scale, a newly introduced scale in the literature, is examined; It attracts attention because the items are very simple for patients to perceive, combine cognitive tests and cognitive questionnaires, have a short application period, and have not shown a ceiling or floor effect in previous studies. For all these reasons, this study was planned to conduct the Turkish validity and reliability study of the Brief Assessment of Cognitive Impairment Scale.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Stroke Brain Diseases Cardiovascular Diseases Central Nervous System Diseases Cerebrovascular Disorders Cognition Nervous System Diseases Vascular Diseases

Age range

40 year–75 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Ataturk University

Erzurum, Turkey (Türkiye)

About this study

Cognition; It is a broad concept that includes mental processes such as an individual's perception, understanding, processing and remembering of information. Cognition includes many mental activities such as thinking, learning, memory, problem solving, attention, and language use. The importance of cognition is related to the individual's ability to understand his environment, learn, solve problems and make effective decisions in daily life. These processes can have a direct impact on an individual's education, work, relationships, and overall quality of life. Therefore, understanding and supporting cognition can help individuals manage and improve their lives more effectively.

A common consequence of stroke is impaired cognition. It is stated that in the three-year period after stroke, up to 39% of patients have cognitive impairment. There is a significant relationship between cognitive abilities and functional performance. Therefore, cognitive impairment may reduce the independence of people with stroke in performing basic activities of daily living (such as eating, dressing, and toileting) and activities of daily living (such as household chores and social interactions). As a result, people with post-stroke cognitive impairment often require ongoing care and support, which can put pressure on caregivers and society. Therefore, effective assessment of post-stroke cognition is crucial for stroke rehabilitation. Frequently used assessment methods in the cognitive evaluation of stroke patients include scales and tests such as Mini Mental State Test, Montreal Cognitive Assessment Scale, and Wechsler Memory and Intelligence Test. However, when these evaluations are examined, there are problems in detecting the cognitive effects of patients with different severities due to the long application times of some of them and the floor and ceiling effects in some of them. Therefore, we planned this study to test the Turkish validity and reliability of the Brief Assessment of Cognitive Impairment Scale, a new, simple diagnostic tool that combines cognitive tests and cognitive questionnaires, in stroke patients.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Individuals between the ages of 40 and 75,
  • Individuals who volunteer to participate in the research,
  • Individuals diagnosed with stroke,
  • Individuals who do not have cooperation and communication problems

Exclusion criteria

  • Those with neurological problems other than stroke (patients diagnosed with Alzheimer's, Parkinson's, Dementia, MS)
  • Those with perceptual problems
  • Individuals with cooperation and communication problems

Treatment and study plan

Reliability and validity study

Other

Reliability and Validity Study

Primary outcomes

  1. Brief Assessment of Cognitive Impairment Scale

    Time frame: seven day

    The Brief Assessment of Cognitive Impairment was developed by Danish researchers to assess cognitive impairment and dementia. To practice BASIC, one needs a registration form, a picture card, a manual, and a stopwatch, like the stopwatch in our smartphone's clock app. BASIC consists of five parts: presentation of pictures for memory testing, patient-directed questions, fluency in naming supermarket products, recall of pictures, and assessor-directed questions. Assessor-directed questions can be administered before, during, or after the patient is evaluated. It is performed for evaluation in an environment free from distractions and with adequate lighting. If the patient uses glasses or hearing aids, these must be present. It is necessary to explain the purpose of the evaluation to the patient. The test consists of 11 questions. The lowest score is 0, the highest score is 25. As the score decreases, cognitive status worsens.

Secondary outcomes

  1. Mini Mental State Test

    Time frame: seven day

    The test develoThe test developed by Folstein et al. in 1975 is the most widely used cognitive screening test. The test consists of 11 items; It is evaluated out of 30 points: 10 points for time and space orientation, 6 points for memory, 5 points for attention, 8 points for language and 1 point for visual-spatial function. 24-30 points are considered normal, 18-23 points are considered mild cognitive impairment, 12-17 points are considered moderately severe, and below 12 points are considered severe cognitive impairment. A standardized MMDT was created for the Turkish society and validity and reliability tests were conducted.

  2. Sociodemographic Assessment

    Time frame: seven day

    Before individuals; Parameters such as age, gender, marital status, educational status, profession, Brunnstrom level, stroke duration, side of stroke, affected vein, dominant extremity, smoking and alcohol use, assistive devices used, CV information, family history information and medications used will be questioned.

Sponsors and collaborators

Lead sponsor

Ataturk University

Other

Registry information

Official study title

Examination of the Validity and Reliability of the Turkish Version of the Brief Assessment of Cognitive Impairment in Individuals With Stroke Scale

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Mar 15, 2024
Registry last updated
Feb 11, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.